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Abstract
The system-level dynamics of multivalent biomolecular interactions can be simulated
using a rule-based kinetic Monte Carlo method in which a rejection sampling strategy
is used to generate reaction events. This method becomes inefficient when simulating
aggregation processes with large biomolecular complexes. Here, we present a rejection-
free method for determining the kinetics of multivalent biomolecular interactions, and
we apply the method to simulate simple models for ligand-receptor interactions. Sim-
ulation results show that performance of the rejection-free method is equal to or better
than that of the rejection method over wide parameter ranges, and the rejection-free
method is more efficient for simulating systems in which aggregation is extensive. The
rejection-free method reported here should be useful for simulating a variety of systems
in which multisite molecular interactions yield large molecular aggregates.
Key words: Protein-protein interactions, Stochastic simulation algorithm,
Chemical reactions, Ligand-receptor binding
PACS: 82.20.Wt, 82.39.Rt, 82.40.Qt
1. Introduction
Protein-protein interactions in signal transduction involve domain-based pro-
tein interactions and site-specific modifications [1, 2]. Simulating the dynamics
of a complex signaling system that has many protein interactions is usually
a daunting task because a large (bio)chemical reaction network is typically re-
quired to model interactions at the level of site-specific details and submolecular
domains [3, 4, 5, 6]. Even though a large-scale biochemical reaction network can
be built by either manual or automated construction [7, 8, 9, 10], simulating
such models is computationally inefficient because a conventional kinetic Monte
Carlo simulation algorithm, for example, has a cost that depends on the size of
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Figure 1: Diagrammatic depiction of a biochemical system described by rules and its under-
lying reaction network. Rules partition the entire reaction list into disjoint subsets which are
consolidated by rules into rate processes denoted by {η1, η2, ..., ηM}. The term rij denotes
the jth reaction implied by Rule i. Note that partitions of a reaction network specified by
rules are not necessarily of finite size, which is illustrated in our model of multivalent ligand-
receptor interactions (see main text). Rule-based kinetic Monte Carlo samples the rule list
(the intermediate layer) to generate reaction events and avoids simulating a system by means
of a reaction network (the bottom layer).
a network measured by the number of reactions [11] or the number of chemical
species [12].
The challenge of simulating protein-protein interactions in signal transduc-
tion can be addressed with a rule-based modeling paradigm (see Ref. [4] for a
review). Rule-based modeling provides a hierarchical structure to define bio-
chemical reaction systems (Fig. 1). In a rule-based approach, molecules are
modeled as structured objects composed of reactive sites, and reaction rules are
used to represent interactions [4, 13, 14] (see Fig. 2 for examples of rules for
ligand-receptor interactions). In general, a rule specifies local properties of indi-
vidual sites (e.g., whether a site is free or occupied) in a molecule and application
conditions that require checking non-local information (e.g., whether two sites
are members of the same macromolecular aggregate). Assuming rate laws for
elementary reactions, one parameterizes the reaction classes implied by a rule
with a specific rate constant. Thus, a rule provides a compact representation of
these reactions based on the law of mass action.
Kinetic Monte Carlo (KMC) methods have been developed for simulating
the stochastic dynamics of rule-based models [15, 16, 17]. The methods of Danos
et al. [15] and Yang et al. [16] avoid the requirement of specifying a chemical
reaction network prior to simulation by directly sampling a rule list to generate
reaction events and updating the system state in accordance with reaction rules.
The computational cost is essentially independent of network size because a rule
list is typically more compact and orders of magnitude smaller than the size of
the corresponding reaction network.
The rule-based KMC simulation method of Yang et al. [16] involves rejection
sampling. After a rule is selected, trial sites with suitable local properties are
randomly sampled to potentially undergo the chemical transformation(s) spec-
ified by the rule. Trial sites are rejected if they are not compatible with the ap-
plication conditions of the rule. Random site selection in the rejection sampling
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steps is a constant-time operation, but efficiency might be significantly com-
promised in cases where null events become a dominant fraction of all sampled
events. This scenario happens when the method is used to simulate multivalent
ligand-receptor interactions in a sol-gel region that yields a giant ligand-receptor
aggregate at equilibrium, where sampled trial sites are very likely rejected be-
cause the vast majority of sites reside in the giant aggregate and are prohibited
from binding to each other by an application condition (a model assumption)
that prohibits intra-aggregate binding reactions to form cyclic aggregates.
In this work, we present a rejection-free KMC method for simulating the
kinetics of reactions implied by rules. This approach can be used to efficiently
simulate processes involving multivalent biomolecule clustering and aggregation,
processes often encountered in biochemical systems. The method samples sites
for reaction according to their exact probability of taking part in a reaction de-
fined by a sampled rule and consequently avoids rejecting trial sites altogether.
The simulation is statistically exact and is validated by comparing to continuum
solutions of low-dimensional models for multivalent ligand-receptor binding sys-
tem. We simulate a trivalent ligand – bivalent receptor model using the method
of Yang et al. [16] and the rejection-free method. The latter method is found to
have the same or better efficiency for most parameter values.
2. Rule-based kinetic Monte Carlo
In this section, we describe the strategy of rejection-free KMC for rule-based
models. In a biomolecular reaction system, particularly in a system involving
protein-protein interactions for signal transduction, proteins reversibly bind to
one another via their binding sites (conserved domains). Protein sites (amino
acid residues) can also be modified, by phosphorylation, methylation, etc. The
state of the system (or a system configuration) is determined by states of individ-
ual sites and their connectivities. The temporal dynamics of a biochemical reac-
tion system is the evolution of the system state in time, which can be modeled
as a Markov process that is generally described by the Chapman-Kolmogorov
equation (or more specifically, the chemical master equation for our case) [18]:
dP (Y, t)
dt
=
∑
Y ′ 6=Y
[W (Y |Y ′)P (Y ′, t)− P (Y, t)W (Y ′|Y )] . (1)
P (Y, t) is the probability that the system is found in state Y , andW (Y ′|Y ) gives
the transition rate from state Y to state Y ′. In a conventional chemical reaction
system, a state Y is defined by the concentrations of all chemical species. In a
rule-based system, a state Y is defined by the site occupancy and connectivity
of individual molecules. Analytical solutions to the above master equation are
only possible for very simple systems. Direct numerical integration of the above
ordinary differential equations is also intractable because the size of the state
space is often enormous even for a mildly-complex system that involves interac-
tions among a few protein types. To solve this problem, Monte Carlo simulation
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is often applied to conduct random walks over the state space and to generate
stochastic state trajectories for a system of interest.
Here we consider a biochemical system that is described by a set of reaction
rules (see Fig. 1), R = {R1, ...,RM}. The system evolves in time with rates
η= {η1, ..., ηM} for the rules. Such rate processes can be simulated using the
standard kinetic Monte Carlo method [19]. The waiting time τ between two
consecutive (reaction) events is taken to follow an exponential distribution
P (τ) = ηtote
−ηtotτ , (2)
where ηtot =
∑M
i=1 ηi is the sum of the rule rates. The mean waiting time for
a reaction event is the inverse of ηtot, 〈τ〉 =
1
ηtot
. For each reaction event, a
waiting time τ is sampled using the following equation:
τ = −
ln(ρ1)
ηtot
, (3)
where ρ1 is a uniform random number in (0, 1). The probability for a rule to
be chosen is proportional to its rate. Therefore, a specific rule e is sampled by
finding the integer e that satisfies:
e−1∑
i=1
ηi < ρ2ηtot ≤
e∑
i=1
ηi , (4)
where ρ2 is a uniform random number in (0, 1).
The rule-based kinetic Monte Carlo algorithm requires several additional
operations per reaction event following the selections of τ and e: (1) select
reactive sites admissible to the rule; (2) excute the chemical transformation
defined by rule e; and (3) update components in the rate vector η that are
affected by the chemical transformation.
To choose reactive sites, we can write the rule-specific probability for a site
x in a candidate set Xe to be chosen as (we note that a “site” x denotes a
set of interacting protein sites that are defined by the rule. For example, for a
bimolecular interaction, x will include two interacting sites)
P (x) = Pa|s(x)Ps(x) . (5)
This equation describes a two-step procedure to find a site x: (a) choose a
site x according to the sampling probability Ps(x) and (b) accept the chosen
x according to the acceptance probability Pa|s(x). In the rejection method,
a convenient sampling distribution Ps(x) of candidate sites, usually a uniform
distribution for maximum sampling efficiency, is used to generate trial sites and
trial sites may be rejected according to the acceptance probability Pa|s(x) so
that the true probability P (x) is recovered. The rejection sampling introduces a
“null” process by sampling nonreactive sites such that this null process advances
time but does not change the system state. Therefore, we can partition the rate
of a rule into two components:
ηe = ηe,a + ηe,n e = 1, ...,M , (6)
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Figure 2: The interactions of a trivalent ligand and a bivalent cell-surface receptor (left).
Graphical rules (right) that represent free ligand recruitment to the cell surface (Rule 1), re-
ceptor crosslinking by ligand (Rule 2) and ligand-receptor bond dissociation (Rule 3). Rules
are parameterized by rate constants k+1, k+2 and koff , respectively. An empty (filled) circle
inside a container denotes a free (bound) site. A connecting line indicates a ligand-receptor
bond. An empty container indicates an arbitrary state (free or bound). An additional as-
sumption is imposed to prohibit reactions defined by R2 from forming cyclic ligand-receptor
aggregates (see main text).
where ηe,a and ηe,n denote the actual reactive rate and the null process rate
of rule e, respectively. Generally, the size of the null fraction of ηe,n depends
on the site sampling procedure which also affects the calculation of the rule
rate. Operating with the combined rate ηe ignores any application condition
by model assumption imposed on this rule in the step of site sampling. The
model assumption can however be enforced by a subsequent rejection of the
sampled sites that are non-permissible to react. Because the rejection method
often can achieve random sampling of reactive sites, the cost per sampling step
is constant and the implementation is usually straightforward. Determining
whether to accept trial sites for reaction may however incur non-constant cost
and complex bookkeeping, which depends on the nature of model assumptions.
The effect of rejection sampling on computational performance can be mea-
sured by the rejection ratio:
θ =
ηtot,n
ηtot
, (7)
where ηtot,n =
∑M
i=1 ηi,n is the total rate of null processes. For some systems
where θ may be close to 1, a majority of trial sites will be rejected and the algo-
rithm becomes inefficient. For such situations, an algorithm without rejections
(or with a substantially reduced number of rejections) is desirable.
In contrast, a rejection-free method always accepts sampled site x. In other
words, Pa|s(x) is unity for every x and P (x) is captured at the step of site
sampling, i.e., P (x) = Ps(x).
An early rejection-free Monte Carlo simulation method was developed by
Bortz et al. [20] to simulate Ising spin systems, which overcomes the signif-
icant slowing down near the critical temperature by the classic Metropolis
method [21]. The algorithm is often called the BLK algorithm, or the n-fold
way method, and it has been widely used to simulate systems with high density
and/or at low temperature. Gillespie later developed a stochastic simulation
algorithm, equivalent to the method of Bortz et al. [20], for simulating coupled
chemical reactions in a homogeneous reaction compartment [22]. Below, we
describe a rejection-free procedure for simulating rule-based models.
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Without loss of generality, we only consider unimolecular and bimolecular
reactions. Higher-order reactions can usually be decomposed into these two
types of elementary reactions. For a unimolecular reaction (e.g., a single-step
site modification or a noncovalent bond dissociation between two proteins) of
rule e that involves a single type of protein site A, at a given time, the candidate
sites are defined in a set Xe = {ai|i = 1, ..., na} that includes all legitimate
sites designated by the rule and its application conditions. In many cases, by
the mean-field approximation, sites available according to a rule definition are
considered to have equal probability to be chosen. The probability of a site
x = ai to be chosen is
P (x = ai) = Ps(x = ai) =
wi
Z
(8)
where wi is the reaction propensity for site ai and Z is a partition function Z =
ηe =
∑
Xe
wi. In general wi reflects the biophysical property that determines
the reaction propensity of the site ai. In most applications, a rule usually defines
reactions of sites from the same protein types and with identical properties. For
this reason and under the law of mass action, we can interpret wi as the specific
rate (or, the rate constant) ke for the rule. The partition funtion becomes the
total rule rate, Z = ke|Xe|, where |Xe| denotes the size of the candidate set
Xe (i.e., |Xe| = na). Effectively, Eq. 8 defines a uniform sampling distribution
over Xe. The above analysis can be readily extended to the case of bimolecular
reactions. Considering an interaction such as binding between two types of
protein sites A and B, we have a candidate set Xe = {ai, bj |i = 1, ..., na, j =
1, ..., nb}. The probability of a pair of sites x = (ai, bj) to be chosen to react is
P (x = {ai, bj}) = Ps(x = {ai, bj}) =
wij
Z
. (9)
Similarly, wij can be interpreted as a specific rate ke that is identical for all
site pairs. According to the law of mass action, the partition function Z =∑
Xe
wij = ke|Xe| = kenanb.
Based on the above considerations, we summarize the rejection-free algo-
rithm as follows.
1. Initialization: assign copy numbers of proteins and specify initial states
of individual protein sites, assign rate constants k for rules, and calculate
the initial values of η.
2. Sample a waiting time τ and choose a reaction rule e according to Eqs. (3)
and (4), respectively.
3. Sample protein sites based on the distribution P (x), update states of the
chosen sites according to the rule specification, and recalculate rate vector
η.
4. Repeat Steps 2 and 3.
The above steps provide a general strategy for simulating rule-based bio-
chemical reaction systems. In the following section, we apply the method to
simulate a multivalent ligand-receptor interaction model and use the model to
discuss the implementation details.
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3. Multivalent ligand-receptor binding systems
Cell-surface receptor aggregation induced by ligand binding is an important
step in many signal transduction pathways [23]. In an earlier study, Goldstein
and Perelson developed an equilibrium model to investigate binding interactions
between trivalent extracellular ligands and bivalent cell-surface receptors [24].
The Goldstein-Perelson model predicted in theory that for certain parameter
values small receptor aggregates and “superaggregates” can coexist at equilib-
rium. In fact, sol-gel phase transition phenomena can happen in any multivalent
ligand-receptor system in which either the ligand or the receptor has more than
two binding sites and each ligand and receptor has at least two binding sites.
Recently, Yang et al. [16] developed a rule-based kinetic Monte Carlo method
that was used to simulate the stochastic dynamics of a kinetic version of the
Goldstein-Perelson model, which has been called the TLBR model, where TLBR
represents “trivalent ligand – bivalent receptor.” The gelation processes of ligand-
receptor aggregation were observed in simulations, which was consistent with
the Goldstein-Perelson theory of sol-gel phase transition. The simulation fur-
ther revealed the kinetic details about formation of superaggregates. Monine
et al. [25] also applied the same method to study steric effects using extended
kinetic versions of the Goldstein-Perelson model. The KMC simulation method
of Yang et al. [16] includes rejection sampling, which becomes inefficient when
a system forms a superaggregate that contains most ligands and receptors. In
this section, we evaluate the rejection-free method approach by applying it study
multivalent ligand-receptor interaction systems.
3.1. Model of ligand-receptor binding
We consider a system with NL ligands and NR receptors. The ligand and
receptor have vl and vr symmetric binding sites, respectively. Three types of
reactions are considered: (1) free ligand recruitment to a receptor on the cell
surface, (2) crosslinking of two cell-surface receptors by a ligand that is already
bound on the cell surface but has at least one free site, and (3) dissociation of a
ligand-receptor bond. The rule-based specification of the TLBR model, a kinetic
extension of the Goldstein-Perelson model, is illustrated in Fig. 2. The model
has three reaction rules (Rules 1-3). To compare results with the Goldstein-
Perelson model, we impose the same model assumptions: a) binding sites are
equivalent [26], b) a ligand cannot associate with a receptor via more than one
bond, and c) a ligand cannot associate with a receptor that is a member of the
same aggregate (an aggregate is a ligand-receptor complex that has at least one
ligand and one receptor in it). These assumptions prevent the formation of cyclic
ligand-receptor aggregates and affect the calculation of rule rates, which is the
actual reason that distinguishes rejection and rejection-free sampling prcedures.
3.2. Calculation of rule rates and site sampling
All rule rates are calculated according to the law of mass action. We first
give equations for directly calculating η1 and η3. Calculation of η2 requires
7
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Figure 3: Validation of the simulation algorithm for multivalent ligand-receptor interaction
systems. (a) Comparison of normalized results to the ODE solutions for the bivalent ligand
and bivalent receptor interaction system. The normalization factor is NR/n, where n is the
number of receptors in an aggregate (n = 2 for dimers, n = 3 for trimers, etc.). The means and
standard deviations of the simulation results obtained by the simulation method are shown
on top of the continuous ODE solutions. One stochastic time trajectory is shown for the free
receptor population. (b) Stochastic receptor aggregate distribution for the trivalent ligand
and bivalent receptor system. The system reaches equilibrium after 350 seconds and the
averages of equilibrium distributions match the results (solid curve) obtained using the model
of Goldstein and Perelson [24]. Parameter values: NR = 300, NL = 4200, k+1 = 6.67× 10
−7
s−1, k+2 = 100k+1, koff = 0.01 s
−1. Initial condition: all simulations start with free ligands
and free receptors without bonds.
non-trivial treatment, and different treatment implies different implementation
of the algorithm. We will explain these issues in detail.
The rate of free ligand recruitment to a cell-surface receptor for Rule 1, η1,
is proportional to the product of the number of free sites on free ligands and
the number of free receptor sites on the cell surface,
η1 = k+1vlFL(vrNR −B) , (10)
where FL is the number of free ligands. We note that Rule 1 specifies a class
of bimolecular reactions and the rate constant k+1 absorbs a volume factor
(this also applies to the rate constant k+2). The rate of ligand-receptor bond
dissociation for Rule 3, η3, is proportional to the number of ligand-receptor
bonds,
η3 = koffB . (11)
The number of bonds B increases (decreases) by 1 upon an association (disso-
ciation) event.
For ligand-mediated receptor cross-linking on the cell surface (an event of
Rule 2), to avoid forming cyclic ligand-receptor aggregates, one must ensure
that an association event joins either two separate ligand-receptor aggregates or
a ligand-receptor aggregate and a free receptor. We note that the probability for
a ligand site to be chosen is proportional to the number of free receptor sites to
which the ligand site may bind, i.e., the number of free receptor sites excluding
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ones in the same aggregate with the candidate ligand site. Once a ligand site is
chosen, the probability of selecting a binding receptor site is uniform for all free
receptor sites that are not in the same aggregate with the selected ligand site.
A straightforward approach is to calculate the probability for each free re-
ceptor site to take part in the next event and the probability for each free ligand
site (on the cell surface) to crosslink the free receptor site. However, the cost of
searching over sites and updating site probabilities would scale with the number
of molecules per Monte Carlo step.
At a given time, if the system has NA ligand-receptor aggregates on the cell
surface (excluding free receptors), the rate η2 can be given by a direct sum over
combinations between distinct aggregate pairs, i.e.,
η2 = k+2

vrFR(vl(NL − FL)−NB) + NA∑
i=1
NA∑
j=1,j 6=i
(lirj + ljri)

 , (12)
where li and ri are the numbers of free ligand and receptor sites in the ith
aggregate, respectively, and FR is the number of free receptors. The term
vrFR(vl(NL−FL)−NB) accounts for the interactions between free ligand sites
on the cell surface and free receptor sites. However, the computational cost of
Eq. (12) is O(N2A), which is impractical when NA is large. Alternatively, rate
η2 can be calculated as
η2 = k+2
NA∑
i=1
li(vrNR −B − ri) , (13)
The term (vrNR−B− ri) is the total number of free receptor sites that are not
in aggregate i. From the above equation, it follows that the probability that an
aggregate i contributes a ligand site for a Rule 2 event is
Pi =
k+2li(vrNR −B − ri)
η2
, i = 1, ..., NA . (14)
We first sample this distribution to locate an aggregate i that provides a free
ligand site. All free ligand sites in aggregate i are equivalent (according to
model assumptions) and therefore each of them has an equal probability to be
chosen. Then, a free receptor site that is not in aggregate i is chosen to bind
with the sampled ligand site. Similarly, all such free receptor sites (either in
another aggregate or in the free receptor pool) are equivalent and therefore
can be randomly sampled. The number of free ligand and receptor sites, li
and ri, can be calculated when the numbers of ligands and receptors in an
aggregate are known. In an acyclic aggregate that has nr receptors and nl
ligands, the number of bonds is given as b = nr + nl − 1, and the numbers of
free receptor and ligand sites can be calculated as r = vlnl− b and l = vrnr− b,
respectively. This corresponds to a graph-theoretic observation that a connected
acyclic graph (equivalent to a tree) has a number of edges one less than the
number of nodes [27]. A ligand-receptor aggregate can be represented as a
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bipartite graph, in which receptors and ligands are nodes and ligand-receptor
bonds are edges. The numbers of receptors and ligands can be obtained by a
linear-time traversal of the aggregate graph. A better, alternative approach is
to maintain an aggregate list during simulation. This approach avoids routine
graph traversal of aggregate graphs for each reaction event except for bond
dissociation events, in which graph traversals are required to determine the
resulting two separate aggregates. Direct calculation of η2 using Eq. (13) has a
linear-time cost scaled by the number of aggregates NA. To achieve a constant-
time cost per event, we update η2 iteratively by accounting for the change caused
by a reaction event. Eq. (13) can be rewritten as follows:
η2 = k+2
(
[vl(NL − FL)−B](vrNR −B)−
NA∑
i=1
liri
)
. (15)
The term [vl(NL−FL)−B](vrNR−B) accounts for all pair combinations of free
ligand sites (on the cell surface) and free receptor sites under the law of mass
action. We note that, in a method using rejection sampling [16], this quantity
is used to calculate rate η2 and a trial pair of ligand and receptor sites can
be randomly chosen but are subject to rejection later if they are found to be
components of the same aggregate. For our rejection-free implementation, the
exact rate is obtained by subtracting u ≡
∑NA
i=1 liri, where u is the number of
intra-aggregate site-pair combinations, to accommodate the model assumption
that prohibits intra-aggregate binding reactions. The first term in Eq. (15)
can be easily recalculated with a constant cost after each reaction event. The
second term can be updated iteratively by ∆u (Table 1). Each reaction event
changes the list of aggregates by creating a new one, or modifying or removing
existing ones. For instance, a free ligand binding to a receptor may (if the
receptor is also free) or may not (if the receptor is already bound to another
ligand) create a new aggregate. However, most aggregates do not participate in
a reaction event and thus remain unchanged. Therefore, updating Eq. (15) is
straightforward by accounting for sites on a small number of affected aggregates
(usually one or two) and it has a constant-time cost. For example, a merge of
two aggregates i and j creates one new aggregate k (NA decreases by 1). In
this case, on the newly-formed aggregate, free ligand and receptor sites both
decrease by 1 from the sums of those on the two merging aggregates, and it
follows that ∆u = lkrk − liri − ljrj , where lk = li + lj − 1 and rk = ri + rj − 1.
Formulas for all event types are given in Table 1.
Our implementations of the rejection method of Yang et al. [16] and the
rejection-free method reported here are available upon request. These imple-
mentations simulate the TLBR model, as well as models for m-valent ligand
and n-valent receptor that incorporate model assumptions similar to those of
the Goldstein-Perelson model. The rejection and rejection-free codes were writ-
ten with the intention of making them as much alike as possible, except for
the sampling strategies and rule rate calculations, to eliminate irrelevant differ-
ences. We note that our implementations of the simulation methods discussed
here provide new tools for studying the equilibria and kinetics of multivalent
10
Table 1: Formulas for calculating ∆u2
Rule Event ∆u2
1 A free ligand binds to a free receptor (vr − 1)(vl − 1)
A free ligand binds to aggregate i (vl − 1)(ri − 1) − li
2 Aggregate i associates with a free receptor (vr − 1)(li − 1)− ri
Aggregates i and j associate to form a new aggregate k lkrk − liri − ljrj
3 An aggregate breaks into a free ligand and a free receptor −(vr − 1)(vl − 1)
A ligand dissociates from aggregate i li − (vl − 1)(ri + 1)
A receptor dissociates from aggregate i ri − (vr − 1)(li + 1)
Aggregate k dissociates into two aggregates i and j liri + ljrj − lkrk
ligand-receptor interactions and gelation on cell membranes, topics which have
been studied intensely over the years via a variety of approaches [28, 29, 30, 31].
4. Simulation results
In this section, we present results obtained using the rejection-free algorithm
described above. Parameter values used in simulations were taken from Ref. [16].
To validate the accuracy of our method, we compare simulation results with
those obtained using ordinary differential equations (ODEs). The relaxation
kinetics of a bivalent ligand (vl = 2) – bivalent receptor (vr = 2) system to
equilibrium is shown in Fig. 3(a). The deterministic results were obtained by
solving a small number of ODEs as described in Refs. [26, 32]. The stochastic
trajectories recapitulate on average the deterministic solutions. In Fig. 3(b),
the equilibrium distribution of receptor aggregates in a TLBR system agrees on
average with the equilibrium results from the Goldstein-Perelson model. These
results demonstrate that the simulation algorithm produces outcomes consistent
with those obtained independently.
A phase transition in ligand-receptor clustering at equilibrium is predicted
in the Goldstein-Perelson model by varying two dimensionless parameters ctot =
3k+1NL/koff and β = k+2NR/koff , which shows that finite-sized ligand-receptor
aggregates can coexist with an infinite-sized polymer-like aggregate in a so-
called sol-gel coexistence regime [24]. To investigate the stochastic dynamics of
ligand-receptor aggregation and the algorithmic performance at different phase
regimes, we use the average receptor aggregate size to measure the degree of
ligand-receptor clustering, which can be calculated as
Γ =
NR∑
n=1
npn =
1
NR
NR∑
n=1
n2xn , (16)
where n is the size of a ligand-receptor aggregate measuring the number of
receptors in the aggregate and xn is the number of aggregates of size n. The
term pn = nxn/NR is the fraction of receptors in aggregates of size n, which
corresponds to the probability of finding an arbitrary receptor in an aggregate of
size n. We note that in the above equation the number of aggregates containing
single receptors, x1, accounts for all receptor monomers including free receptors.
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Figure 4: The relationship between 〈NA〉 and NR for the trivalent ligand–bivalent receptor
system. The number of ligands NL is set equal to the number of receptors NR. 〈NA〉 is
obtained by calculating its mean value from 106 consecutive reaction events after the sys-
tem reaches equilibrium. Other parameters and initial conditions are identical to the values
indicated in Fig. 3.
Therefore, at any given time the average aggregate size Γ takes a value in the
interval [1, NR]. In practice, since the number of aggregates NA is always much
less than NR (Fig. 4), Γ can be equivalently and more efficiently calculated with
the following equation:
Γ =
FR
NR
+
1
NR
NA∑
j=1
n2j , (17)
where FR is the number of free receptors and nj is the number of receptors in
aggregate j. The average aggregate size Γ can be also calculated iteratively dur-
ing a simulation by accounting for the changes of aggregation caused by reaction
events. To study the effect of the degree of aggregation on algorithmic efficiency
by adjusting the parameters ctot and β, we ran simulations of the TLBR model
to equilibrium under a set of different values of the dissociation rate constant
koff in the range between 10
−6 s−1 and 100 s−1, with both NL and NR fixed at
5000. Figure 5(a) shows a sigmoid-like relationship between the mean average
aggregate size 〈Γ〉 and the dissociation rate constant koff . At smaller koff (sol-gel
region), 〈Γ〉 approaches its maximum value (close to the number of receptors
NR), which indicates that a large aggregate containing most receptors exists
in the system. At larger koff (sol region), 〈Γ〉 approaches its minimum value,
indicating that the majority of receptors are in the form of free receptors and
ligand-bound receptor monomers. The mean aggregate number 〈NA〉 exhibits
a bell-shaped curve with a maximum value of 966 near the phase transition
boundary at koff = 0.17. Figure 5(b) shows the performance comparison be-
tween the rejection-free method described in this work and the rejection method
of Yang et al. [16] in terms of CPU time per reaction event, for the TLBR model
with a typical set of parameters. In most of the sol region (koff > 1 s
−1) and
near the sol-gel region (10−4 s−1 < koff < 10 s
−1), the rejection-free and re-
jection methods match each other in performance, and the efficiency of both
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Figure 5: Performance comparison of the rejection-free method and the rejection method. (a)
The mean average aggregate size 〈Γ〉 (solid line) and the average number of aggregates 〈NA〉
(dashed line). The results are normalized by the total number of receptors, NR. Simulation
parameters: vr = 2, vl = 3, NR = NL = 5000. (b) Relationship between CPU time and
koff : rejection-free method (solid line), rejection method of Yang et al. [16] with aggregate
bookkeeping (dashed line). (c) The relationship between the rejection ratio θ and the mean
average aggregate size 〈Γ〉. CPU times per reaction event, 〈Γ〉 and 〈NA〉 are calculated by
averaging over 200,000 reaction events after simulations reach equilibrium. Other parameters
and initial conditions are the same as indicated in Fig. 3.
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Figure 6: (c) Scaling with number of binding sites on the ligand (vl). For both the rejection-
free (squares) and the rejection (circles) simulations, the receptor valence is fixed at vr = 2 and
the copy numbers of receptor and ligand are NR = NL = 1000. CPU times per reaction event
are calculated by averaging over 200,000 reaction events after simulations reach equilibrium.
Other parameters and initial conditions are the same as indicated in Fig. 3.
methods deteriorates as 〈Γ〉 increases. The rejection-free method is affected
by searching over a near maximum number of aggregates, which is reflected in
the increases of CPU time per reaction event near the boundary of the phase
transition (10−1 s−1 < koff < 1 s
−1) compared to that of the rejection method.
However, the rejection-free method is less sensitive to 〈Γ〉 and outperforms the
rejection method in the highly-aggregated sol-gel region (koff < 10
−4), where
the rejection method has a rejection ratio θ greater than 99% at equilibrium.
As shown in Fig. 5(c), the rejection ratio θ has a near log-linear dependence on
Γ over a wide range.
To investigate the effect of valence, we varied the number of ligand binding
sites vl and kept receptor valence fixed at vr = 2 (Fig. 5(b)), which can be
accomplished experimentally through synthesis of multivalent ligands [33, 34,
35]. Compared to the method of Yang et al. [16], the rejection-free method has
better scaling of CPU time per reaction event with the increase of vl compared to
the rejection method. Except for the system with bivalent ligands, the rejection-
free method is almost insensitive to changes in the number of ligand binding
sites, whereas sampling by the rejection method involves large numbers of null
events due to increases in intra-aggregate combinations of available ligand and
receptor site pairs.
5. Discussion
We have presented a rejection-free method for simulating biochemical re-
action models specified by reaction rules. A kinetic Monte Carlo procedure is
applied to sample the rule list, identify reactant proteins, and update protein
states. In this procedure, all chemical species are formed dynamically. For this
reason, our method has a computational cost independent of reaction network
size. The implementation described here is a rejection-free method in which
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every Monte Carlo step changes the state of the system. The method accounts
for the exact rates of reaction rules and probability distributions of protein
sites, including rules that require evaluation of non-local state information. In
a more general and straightforward implementation, selecting candidate reac-
tant sites based on these probability distributions incurs linear-time cost per
reaction event scaled by the number of sites. In contrast, the rejection-free
implementation reported here in fact scales with the number of existing chem-
ical species. In the multivalent ligand-receptor interaction model, the number
of chemical species during a simulation corresponds to the number of ligand-
receptor aggregates, NA. Although the rejection-free method has a higher cost
per Monte Carlo step because of searching candidate sites and extra bookkeep-
ing required for calculating probabilities for sites, the method outperforms the
rejection method when the rejection ratio θ approaches unity. Our method is
closely related to the direct simulation Monte Carlo (DSMC) method devel-
oped to simulate coagulation processes where irreversible particle aggregation
is considered [36].
A comparison between rejection-free and rejection methods was briefly dis-
cussed by Yang et al. [16]. The rejection-free algorithm reported by Yang et
al. [16] takes a strategy of searching for a ligand-receptor site pair for cross-
linking, which is less efficient for simulating formations of large ligand-receptor
clusters in comparison to the algorithm presented in this report. This earlier
algorithm maintains reaction probabilities of all sites for searching, which has
a cost of CPU time per reaction event scaling with the number of molecules.
In contrast, the current method searches over an aggregate list that is compact
compared to the full list of molecule sites. For example, as shown in Fig. 5(a),
the maximum number of aggregates on average (observed around koff = 0.1
s−1) was less than one fourth of the total number of receptors (NR = 5000). At
other values of koff , 〈NA〉 is much less than NR (Fig 5(a)). As shown in Fig. 4,
at equilibrium 〈NA〉 has a moderate (sublinear) dependence on the number of
molecules.
Both rejection and rejection-free methods require explicitly tracking con-
nectivity between sites. This feature erodes the efficiency of simulation. In
simulating the multivalent ligand-receptor binding model, to process an aggre-
gate dissociation, at least one unweighted traversal of an aggregate subgraph
is necessary (with no prior information about which subaggregate is smaller).
This presents a major bottleneck to simulating systems in the sol-gel regime
because a graph traversal has an order of cost proportional to the size of the
aggregate. In the sol-gel regime, most graph traversals will happen on the giant
aggregate that has a size close to that of the entire system. Experiments can
provide some information about the composition of a protein aggregate but the
intra-aggregate (or intra-multiprotein complex) topology usually cannot be re-
solved. To compare with data, it may be possible to simulate a system without
tracking the aggregate topology if prediction of connectivity information (e.g.,
distribution of aggregate topologies for an aggregate size) is not of interest.
In summary, our results suggest that a rejection-free kinetic Monte Carlo
approach to simulation of rule-based models has appeal for simulating aggrega-
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tion processes, which are common in many biochemical systems. Although our
implementation in this study is problem-specific for multivalent ligand-receptor
interactions, our results suggest that a generalized implementation of rejection-
free procedures along the lines presented here into existing rule-based modeling
software may be beneficial.
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